A novel interferon-alpha inhibitor reduces histopathological complications in a mouse model of hiv encephalitis
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Poster
- By: SHAWAHNA, Ramzi (An-najah national university, Pharmacy, Nablus, Palestinian Territory)
- Co-author(s): Fritz-French, Cari (Emory University School of Medicine, Department of Neurology, Atlanta, United States of America)
Tyor, William R. (Emory University School of Medicine, Department of Neurology, Atlanta, United States of America)
Background: HIV-associated neurocognitive disorders (HAND) are still highly prevalent in HV seropositive patients. Interferon-alpha (IFNα) has been identified as a key player in the neuropathology of HAND and HIV encephalitis (HIVE). Ongoing studies have suggested that B18R, a novel IFNα inhibitor, can alleviate HIVE pathology.
Aims: We.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.